Another Cancer Phony Exploits Lymphoma to Earn Cash

Another cancer phony makes the news, and much like those before her, she used lymphoma as part of her scam.

This time, she's a 31-year-old woman from Lincoln, Neb., named April Nesslein, and she's been arrested for soliciting and accepting donations from members of her church in order to help pay her bills because, she said, she had a mere three months to live.

Obviously, Nesslein was very short-sighted there. Three months? The best cancer phonies say at least six months, if not more.

She faces a felony charge of theft by deception.

Over $10,000 in Two Months

In the span of two months, from the start of September to the end of October, Nesslein's moaning and whining that she was dying of cancer and needed money to pay her rent and groceries scored her almost $12,000, according to police.

Over the fall, the Nebraska Department of Health and Human Services got in touch with Lincoln police, informing them that Nesslein was taking money from people for medical conditions she did not have.

Specifically, Nesslein said she had been diagnosed with "brain tumors and stage four lymphoma."

Like the lowlifes before her, Nesslein exploited blood cancers. It is quickly becoming impossible to deny the fact that when people fake cancer, they have a tendency to go with blood cancer – either leukemia or lymphoma.

I can think of a few reasons why they might choose a blood cancer, but I'm not about to give credit to these messed-up people for being smart enough to know why they're choosing it.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap